Increased Cardiac Myocyte PDE5 Levels in Human and Murine Pressure Overload Hypertrophy Contribute to Adverse LV Remodeling by Sara Vandenwijngaert (390970)

“…LV hypertrophy and fibrosis were similar as in WT, but PDE5-TG had increased cardiac dimensions, and decreased dP/dt_max and dP/dt_min with prolonged tau (<i>P</i><0.05 for all). …”

Transcriptome comparison of <i>C. glutamicum</i> wild type (wt) and the Δ<i>copRS</i> deletion mutant after cultivation in CGXII minimal medium supplemented with 21.25 µM CuSO<sub>... by Stephanie Schelder (213218)

“…<p>The mRNA ratios shown represent mean values from five independent DNA microarray experiments starting from independent cultures. …”

Physiological responses to MD stress among banana leaves. by Baolin Kan (12936933)

Niclosamide functions like BafA1 in inhibiting RBD uptake and neutralizing the endosomal pH. by Chaitra Prabhakara (11114263)

Reducing age bias in decision analyses of anticoagulation for patients with nonvalvular atrial fibrillation – A microsimulation study by Matthew A. Pappas (5504363)

“…</p><p>Results</p><p>Previously-used weighting ratios (1.5) are close to our derived mean weighting ratio (1.60). …”

Dynamics of thrombodynamics parameters throughout the hospital stay. by Ekaterina M. Koltsova (5464523)

Parameters of the thrombodynamics in IE patients and healthy volunteers at admission. by Ekaterina M. Koltsova (5464523)

Dynamics of routine coagulation tests throughout the hospital stay. by Ekaterina M. Koltsova (5464523)

IFN-γ^Ncr1-ON mice are protected against lethal VACV infection. by Katharina Borst (5593826)

“…<p>WT, IFN-γ^OFF, IFN-γ^CD4-ON and IFN-γ^Ncr1-ON mice were i.v. infected with 2 x 10⁶ pfu VACV. …”

Permutation feature importance scores. by Saurav Bose (10213892)

Coagulation parameters in patients receiving and not receiving antithrombotic (ATT) therapy at admission (with anticoagulants or antiplatelet agents). by Ekaterina M. Koltsova (5464523)

Coagulation parameters in patients receiving and not receiving ancoagulant (AK) therapy at admission. by Ekaterina M. Koltsova (5464523)

Data_Sheet_1_The course and determinants of post-traumatic stress over 12 months after hospitalization for COVID-19.PDF by Knut Stavem (4256077)

“…</p>Conclusions<p>The level of PTSD symptoms decreased from 1.5 to 3 months after hospitalization, but did not decrease further to 12 months, and there was no association between PTSD symptoms and COVID-19 disease severity.…”

Physiological recordings of mean blood flows in the umbilical vein (UV), umbilical artery (UA) and the arithmetic derivation of UV-UA flow in a newborn lamb during consecutive uter... by Fiona J. Stenning (10987803)

CA-induced MTT and crystal violet reduction and protection by Ber in N2a cells. by Xiaofeng Liu (35910)

“…<p>CA decreased cell viability in a dose-dependent manner as determined by MTT and crystal violet assay (<b>A</b>) and Ber increased cell viability in a dose-dependent manner until to 25 μg/ml in 2.5 nmol/L CA-treated cells (<b>B</b>). 25 μg/ml Ber showed significant protection of the cells from CA-induced lesions. …”

Discovery of Novel <i>N</i>‑Hydroxy-1,2,4-oxadiazole-5-formamides as ASM Direct Inhibitors for the Treatment of Atherosclerosis by Kan Yang (49193)

Figure S1 - The RNA Degradation Pathway Regulates the Function of GAS5 a Non-Coding RNA in Mammalian Cells by Hidenori Tani (169942)

“…<p><b>Knockdown of UPF1 increases the expression level of GAS5, and decreases the glucocorticoid-responsive genes.…”

X-Linked Alport Dogs Demonstrate Mesangial Filopodial Invasion of the Capillary Tuft as an Early Event in Glomerular Damage by Sabrina D. Clark (3396887)

“…<div><p>Background</p><p>X-linked Alport syndrome (XLAS), caused by mutations in the type IV collagen COL4A5 gene, accounts for approximately 80% of human Alport syndrome. …”

Dynamics of platelet function parameters throughout the hospital stay. by Ekaterina M. Koltsova (5464523)

Impact of LVAD support level on infarct size in a dog model of ischemia reperfusion. by Keita Saku (714525)

“…Compared to control (no LVAD support, n = 6), p-LVAD (n = 5) moderately lowers the infarct ratio (<i>p</i> = 0.011), while t-LVAD (n = 5) strikingly decreases the infarct ratio by more than 80% (<i>p</i><0.01). …”